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Abstract 
Background: Gold-nanobeacons (Au-nanobeacons) have proven to be versatile systems for molecular diagnostics 
and therapeutic actuators. Here, we present the development and characterization of two gold nanobeacons com-
bined with Förster resonance energy transfer (FRET) based spectral codification for dual mode sequence discrimina-
tion. This is the combination of two powerful technologies onto a single nanosystem.
Results: We proved this concept to detect the most common fusion sequences associated with the development of 
chronic myeloid leukemia, e13a2 and e14a2. The detection is based on spectral shift of the donor signal to the accep-
tor, which allows for corroboration of the hybridization event. The Au-nanobeacon acts as scaffold for detection of 
the target in a homogenous format whose output capability (i.e. additional layer of information) is potentiated via the 
spectral codification strategy.
Conclusions: The spectral coded Au-nanobeacons permit the detection of each of the pathogenic fusion sequences, 
with high specificity towards partial complementary sequences. The proposed BioCode Au-nanobeacon concept 
provides for a nanoplatform for molecular recognition suitable for cancer diagnostics.
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Background
Gold nanoparticles (AuNPs) have been proposed as 
effective platforms for the development of bio-sensing 
systems, due to their ease of synthesis, surface function-
alization, high surface-to-volume ratio and size-depend-
ent optical properties [1–3] in particular the ability to 
modulate the emission of nearby organic fluorophores in 
a distance dependent manner [4–7]. Au-nanobeacons are 
AuNPs functionalized with a single strand DNA (ssDNA) 
with a hairpin structure, harboring a fluorophore in the 
opposite extremity from the AuNP surface [8–10]. Due 
to their localized surface plasmon resonance (LSPR), 
AuNPs exhibit a high extinction coefficient (normally 
three orders of magnitude higher than conventional 
fluorophores [11]) and may act as a dark quencher upon 
which multiple hairpins may be grafted. In absence of a 
complementary target, the hairpin is in its close confor-
mation, keeping the fluorophores in close vicinity of the 
AuNP, and quenching of the emission is observed. Pres-
ence of a complementary target opens the hairpin struc-
ture and the fluorophores part away from the AuNPs’ 
surface, allowing for partial fluorescence recovery [9]. 
This Au-nanobeacon concept has been used for specific 
and selective sequence recognition with a diversity of 
applications [8, 9, 12–14]. Here we present a hybridiza-
tion based biosensor concept that combines spectral cod-
ification with the Au-nanobeacon technology—BioCode 
Au-nanobeacon. This conceptual biosensor was devel-
oped and optimized for the detection and discrimination 
of similar sequences, such as fusion genes and/or splice 
variants. This BioCode Au-nanobeacon is labeled with a 
fluorophore that ay act as a donor for Forster resonant 
energy transfer (FRET) to an acceptor fluorophore on 
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a second oligonucleotide sequence that, in its turn, will 
hybridize in the vicinity of the donor upon target recog-
nition. This event will generate a characteristic FRET sig-
nal enabling the evaluation of a sample’s composition in 
terms of presence/absence of target sequence [15, 16]—
spectral codification. The specific spectral signature of 
donor and acceptor pairs formed provides an additional 
level of information of the hybridization events occurring 
in solution [17, 18].
The effective sequence selectivity of the BioCode Au-
nanobeacon was demonstrated using the most com-
mon BCR-ABL fusion transcripts (e13a2 and e14a2) 
as a model. The formation of the BCR-ABL fusion 
sequences is dependent on the reciprocal translocation 
between chromosome 9 and 22, originating the Phila-
delphia chromosome (Ph +  chromosome), which is the 
molecular hallmark of chronic myeloid leukemia (CML) 
[19, 20]. This translocation generates very similar mRNA 
sequences to those on the normal (non-fused) chromo-
somes (ABL and BCR genes). Therefore, the resultant 
transcripts may be used for evaluating the discrimination 
capability of the proposed biosensor.
Here, we report the conceptual development of the 
BioCode Au-nanobeacon strategy and demonstrate its 
application towards discrimination of two fusion genes 
isoforms responsible for chronic myeloid leukemia.
Results and discussion
Hairpin design and specificity assessment for FRET based 
Au‑nanobeacon
CML is the result of a reciprocal translocation between 
human chromosome 9 and 22, resulting in a fusion gene 
BCR-ABL that induces cancer cell progression [21]. For 
the BioCode Au-nanobeacon assembly, the loop por-
tion of the hairpin structure was designed to specifically 
detect either the e13a2 or the e14a2 BCR-ABL fusion 
sequence [20, 21]. The palindrome portion (responsible 
for the closed structure of the ssDNA—hairpin confor-
mation) was designed to have a lower melting tempera-
ture (nearest neighbor estimation, nnTm) [22] than that 
of the double strand formed between the loop portion 
and the fusion sequence BCR-ABL (target). Hybridiza-
tion between the different sequences was predicted using 
the software package NUPACK [23, 24]—see Additional 
file 1: Figure S1. The reasoning behind the Au-nanobea-
con configuration is that the AuNP acts both as a scaf-
fold (multiple hairpins on a single platform heightening 
local concentration of recognition probes) and as dark 
quencher for the donor.
The BioCode Au-nanobeacon system relies on the 
FRET mediated talk between fluorophores on the hair-
pin (surface of AuNPs) and the acceptor labeled oli-
gonucleotides. The working principle of the BioCode 
Au-nanobeacon is depicted in Scheme  1. In the closed 
state, the donor is quenched by its proximity to the 
AuNP surface—donor quenching (Scheme  1a, a1); upon 
hybridization to the target (BCR-ABL fusion product), 
the hairpin opens, increasing the distance between donor 
and the AuNP surface causing a partial recovery of fluo-
rescence emission (Scheme 1b, b1). Once the palindromic 
sequence is exposed, the acceptor labeled oligonucleo-
tide hybridizes to it allowing FRET between both fluoro-
phores to occur (Scheme 1c, c1), leading to signal output.
Hybridization of the complementary target (either 
e13a2 OR e14a2 fusion sequences—see Additional file 1: 
Figure S2) and non-complementary or partial comple-
mentary target (ABL and BCR normal expressed genes) 
was experimentally assessed prior to AuNP functionali-
zation. In these experiments, the expected FRET signal 
was only generated in the presence of the fully com-
plementary target, demonstrating that lack of full tar-
get complementarity does not lead to hairpin opening 
(see Additional file 1: Figure S3). As such, these hairpin 
sequences were used to functionalize the AuNPs.
BioCode Au‑nanobeacon synthesis
The synthesized AuNPs presented an average diameter of 
14.6 ± 1.7 nm, whose surface was covered at 45 % with 
thiolated polyethylene glycol (PEG) for increased stability 
in complex aqueous media (see Additional file 1: Figure 
S3). These AuNP@PEG were then functionalized with 
thiol-oligo-fluorophore hairpins: approximately 63 hair-
pins labeled with the Cy3 donor for BioCode-e13 and 93 
hairpins labeled with FAM for BioCode-e14. The UV–Vis 
spectra for the Au-nanobeacons show a decrease in the 
SPR frequencies and a broader full-width-at-half-maxi-
mum. Dynamic light scattering (DLS) and zeta potential 
(ζ-potential) of both constructs are similar and higher 
than the citrate caped AuNP. Together, these data sup-
port a successful functionalization—see Additional file 1: 
Figures S4 and S5 for full characterization. Both BioCo-
des were washed until no fluorescence was detected on 
the supernatants to ensure that there are no free donors 
labeled hairpins in solution, i.e. after the washing steps, 
all the donor labeled oligonucleotides still in solution are 
those bound to the AuNPs’ surface.
FRET based Au‑nanobeacon target detection
The BioCode Au-nanobeacon performance was assessed 
for different experimental conditions: (1) absence of 
target (reaction blank); (2) non-complementary target 
(negative reaction); (3) oligonucleotides harboring either 
the e13a2 or the e14a2 fusion site, depending on the Au-
nanobeacon (positive reaction); and (4) absence of target 
and acceptor (donor blank). The donor blank provides 
the highest fluorescence intensity of the donor due to 
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minimization of nanoparticle surface energy transfer 
(NSET [25]) and in the absence of FRET (energy transfer 
from the donor to the acceptor labeled oligonucleotide); 
whereas the reaction blank and negative reaction indicate 
the basal fluorescence of the assay in absence of FRET. 
This calibration is of paramount relevance considering 
the cross excitation of the acceptors at the excitation 
wavelength of the donor, which needs to be “corrected” 
to allow for clear signal output [16].
Fluorescence emission spectra for all conditions were 
collected after the hybridizations events (see experimen-
tal section for details). Upon excitation at 495 (donor 
FAM—BioCode-e13) or at 550  nm (donor Cy3—BioC-
ode-e14), the donor/acceptor pair formed in solution 
is revealed through the increased fluorescence of the 
respective acceptor (ROX or Dy-520XL mega Stokes) at 
605 and 650  nm, respectively. These spectra were com-
pared to the control reactions (Fig. 1a, b).
Figure 1a shows the emission spectra of BioCode-e13 
designed to detect the fusion sequence e13a2, where the 
FRET signal of the Au-nanobeacon hybridized to the 
fully complementary target (solid black line) presents 
the highest fluorescence intensity. Here, the donor is 
displaced from the surface of the AuNP (lower NSET 
quenching) and free from the presence of the acceptor 
(not quenched by FRET). In absence of target (reaction 
blank—solid light gray) or in presence of a non-com-
plementary target (reaction negative-dark grey line), 
donor quenching is evident (closed loop conforma-
tion). In this situation, the background emission at 
605 nm results from the direct excitation of the accep-
tor at 495 nm, since no opening of the hairpin occurred. 
When the complementary target and acceptor labeled 
oligonucleotide are present in solution (positive reac-
tion—dashed black line), both the donor and acceptor 
increase their emission bands when comparison to the 
previously described situation. The donor emission in 
the positive reaction increases due to the increase in 
distance with respect to the AuNP surface but suffers a 
decrease due to the energy transfer to the acceptor and, 
therefore, does not reach values as high as for the donor 
blank. Since all fluorophore and NP concentrations are 
kept the same, FRET shows a clear signature on the 
emission increase at 605 nm, with respect to the direct 
excitation emission observed in the controls. Therefore, 
the partial recovery of fluorescence of the donor cou-
pled to the increase of the fluorescence of the acceptor 
is a dual channel specific hybridization spectral signa-
ture. This presents a crosscheck confirmation over the 
same hybridization event. The same behavior can be 
observed for BioCode-e14 designed to detect the e14a2 
sequence—Fig. 1b.
Scheme 1 Schematic representation of the BioCode Au-nanobeacon. a The hairpin in its closed conformation strongly suppresses fluorescence.  
b A complementary target disrupts the hairpin and the donor breaks away from the AuNP surface leading to partial recovery of the donor’s fluores-
cence. c Hybridization to the target sequence exposes the palindromic sequence, which can then be targeted by the acceptor labeled oligonucleo-
tide triggering the emission of fluorescence signal due to the specific FRET between the fluorophores that codify each possible target sequence 
(spectral codification)
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The dual channel spectral signature—BioCode—was 
used to follow the hybridization process over time. The 
channels were defined as follows: (1) donor channel is 
the integrated emission between 506 and 560  nm (for 
donor FAM—BioCode-e13) or the integrated emission 
between 559 and 600 nm (for donor Cy3—BioCode-e14); 
(2) acceptor channel is the integrated emission from 600 
to 700  nm (Acceptor-ROX) or 650–800  nm (Acceptor-
Dy); the acceptors limits were set to minimize contribu-
tion from donor emission. All data was normalized to 
the fluorescence signal prior to the addition of target (I0). 
For BioCode-e13, the evolution of the emission chan-
nels upon addition of BCR-ABL—Fig.  2a, b, non-com-
plementary target (Fig. 2c, d), BCR (Fig. 2e, f ) and ABL 
(Fig. 2g, h) show that only the fully complementary tar-
get leads to the simultaneous increase in both channels. 
Addition of BCR induces a slight a change in the signal 
of the donor channel but no significant variation in the 
acceptor channel, showing that the use of two channels 
increases detection selectivity. The same behavior is 
observed for the BioCode-e14 (see Additional file 1: Fig-
ure S6).
Considering that CML presents itself in heterozygo-
sity, any given individual will always harbor one healthy 
copy of ABL and one of BCR. This way, BioCode should 
be able to differentiate between a full- and a non-com-
plementary target, whilst sustaining the influence of the 
partial complementary targets. Table  1 summarizes the 
fluorescence signal percentage for both channels for both 
BioCode after the addition of a non-complementary, 
fully complementary and partially complementary target 
(BCR or ABL) for the most common BCR-ABL fusion 
sequences (e13a2 and e14a2).
The percentage variation of the donor signal for both 
BioCode (after hybridization) shows a clear difference 
between the positive reaction (presence of a fully com-
plementary target), negative reaction (presence of a 
non-related target) and the ABL reaction (partially com-
plementary target). For BioCode-e13, the presence of the 
BCR portion derived from the e13a2 fusion sequence 
Fig. 1 a Emission spectra after hybridization in different reaction condition using BioCode-e13. b Emission spectra after hybridization in different 
reaction condition using BioCode-e14. Emission spectra of donor blank reaction (dashed black line); positive reaction (solid black line); reaction blank 
(solid light grey line); negative reaction (dashed dark gray line)
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Fig. 2 Hybridization assays of BioCode in presence of different target sequences. a BioCode-e13 donor emission in the presence of e13a2 comple-
mentary target (white diamonds); b acceptor-ROX emission in the presence of e13a2 complementary target; c BioCode-e13 donor emission in the 
presence of non-complementary target (black diamonds); d acceptor-ROX emission in the presence of non-complementary target (black diamonds); 
e BioCode-e13 donor emission in the presence of exon 13 BCR derived target (black squares); f acceptor-ROX emission in the presence of exon 13 
BCR derived target (black squares); g BioCode-e13 donor emission in the presence of ABL target (black diamonds); h acceptor-Dy emission in the 
presence of ABL target (black diamonds). The black arrow represents the addition of the target sequence
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generates a donor signal that is comparable with the 
positive reaction (BCR-e13—33.6 % vs. positive—39.8 %, 
respectively). Despite the signal originating from the 
partial hybridization of BCR to BioCode-e13, a clearer 
difference can be observed on the acceptor channel (pos-
itive—53.2  % vs BCR-e13—10.3  %). This illustrates the 
importance of this second channel (acceptors emission) 
for the confirmation over the same hybridization event. 
This second channel profits from the wavelength shift 
mediated by FRET, where the donor’s excitation energy 
is transferred to an acceptor that does not emit at a wave-
length overlapping the AuNPs’ LSPR.
For BioCode-e14, the presence of the BCR sequence 
induces an increase of 26.3 % on the donor channel (also 
in the presence of the ABL sequence—18.2  %), whereas 
the positive reaction induces a 135.6 % increase, allowing 
clear differentiation of both situations. Again, the signal 
variation on acceptor channel is residual for the ABL and 
BCR situations (0.8 and 1.1  %, respectively), while the 
positive reaction shows a clearly higher signal variation 
(50.9  %). See also Additional file  1: Figure S5 for time-
lapse hybridization of BioCode-e14.
The BioCode Au-nanobeacon concept may be eas-
ily expanded to further targets, allowing for the evalua-
tion of complex traits resulting from combination of the 
expression of several loci.
Conclusions
We present a novel concept—BioCode Au-nanobe-
acons—suitable for the selective detection of similar 
targets in solution. This FRET based Au-nanobeacon 
system was applied to the selective detection of specific 
molecular targets that are of clinical interest for real life 
situations. As proof-of-concept, we designed the Bio-
Code Au-nanobeacons to detect either one of the most 
common fusion sequences causing chronic myeloid leu-
kemia, e13a2 and e14a2. The BioCode is a single-step 
detection strategy based on a two successive hybridiza-
tion events: hybridization of the target molecule opens 
the nanobeacon and allows for partial recovery of the 
donor’s emission and exposes the palindrome sequence 
that is the target for the acceptor labeled oligonucleotide. 
The FRET signal is generated solely under selective rec-
ognition of the complimentary target, overlooking any 
signal originated by the presence of partially complemen-
tary targets. This is of utmost relevance since unequivo-
cal detection for similar sequences, such as CML, must 
exclude the unwanted hybridization events resulting 
from healthy ABL or BCR expressed mRNAs that are 
always present in any given sample. The cross-reactivity 
of the healthy counterparts is the most common reason 
for false positive results in current molecular characteri-
zation methods for CML.
Methods
All reagents were of analytical grade and purchased from 
Sigma Aldrich. All oligonucleotides were purchased from 
STABVIDA (Portugal) and used without further purifica-
tion unless stated otherwise.
Fluorophore selection
Donor and acceptor fluorophores were chosen based on 
their spectroscopic characteristics: (1) the donor emis-
sion band should overlay within the LSPR of the AuNP; 
(2) the acceptor’s absorption band should maximize the 
overlap with the donor’s emission; and (3) the emission 
maxima of the acceptors should be distinct to allow iden-
tification of the different emission bands while minimiz-
ing its overlap with the LSPR. From the commercially 
available fluorophores, we selected 6-carboxifluorescein 
(FAM) as donor for BioCode-e13 and sulfoindocyanine 
Cy3 (Cy3) as donor for BioCode-e14; 5-carboxy-X-rho-
damine (Acceptor-ROX) as the acceptor for FAM and 
Dy-520XL mega Stokes (Acceptor-Dy) as the acceptor 
for Cy3. See Additional file 1: Figures S7 and S8 for full 
absorption and emission spectra of these fluorophores.
Hairpin design and target sequences
Au-nanobeacons were designed and the hairpin opti-
mized to specifically detect the BCR-ABL fusion region 
of e13a2 and e14a2 transcript sequence (Accession no. 
AJ131467.1 and AJ131466.1, respectively). The synthetic 
oligomer targets were designed considering several sce-
narios: (1) complementary target (e13a2 or e14a2); (2) 
unrelated non-complementary target, originating from 
an unrelated sequence (NC); (3) one sequence harbor-
ing a partial region derived from exon 2 of the ABL 
gene (ABL); (4) one sequence harboring a partial region 
derived from exon 13 of the BCR gene (BCR-e13); (5) one 
sequence harboring a partial region derived from exon 14 
of the BCR gene (BCR-e14); (6) acceptor sequence com-
plementary to the palindrome sequence of the hairpin 
constituting each nanobeacon. See Table 2 for sequences.













 BioCode-e13 0.5 5.7 33.6 4.0 39.8
 BioCode-e14 8.9 18.2 26.3 1.6 135.6
Acceptors
 BioCode-e13 −8.4 1 10.3 −2.8 53.2
 BioCode-e14 −2.6 0.8 1.1 4.5 50.9
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Evaluation of target selectivity of the designed hairpins
Hybridization of the hairpins to their respective target 
sequence and cross hybridization was evaluated using 
0.5 µM of each hairpin (either e13a2 or e14a2, both marked 
with FAM as donor) or 0.25  µM using both hairpins. 
Reactions were performed in 0.5 ×  TBE pH 8, 154  mM 
NaCl using 1 µM of each target and 0.5 µM each accep-
tor (acceptor-ROX for the e13a2 hairpin; acceptor-Dy for 
the e14a2 hairpin; or both acceptors for both hairpins). 
The positive sample contains the complementary target to 
the respective hairpin; the negative sample contains a non-
complementary target for both hairpins; the ABL reaction 
contains a target with the ABL sequence (common por-
tion of the BCR-ABL fusion product); the BCR contains 
a target with the BCR sequence of each fusion sequence 
(containing either the e14 or e13 portion of the BCR-ABL 
fusion product); the BCR +  ABL reaction contains both 
the non-fused BCR and ABL templates; the cross-template 
reaction contains either the e13a2 template for the e14a2-
hairpin or the e14a2 template for the e13a2-hairpin.
Gold nanoparticle synthesis
Gold nanoparticles with an average size of 14  nm were 
synthesized using the citrate reduction method by Turk-
evich [26] and adapted by Lee and Miesel [27]. Briefly, 
250 ml solution of HAuCl4 at 1 mM was heated until boil-
ing with continuous stirring. Upon reflux, 25 ml of sodium 
citrate at 38.8 mM was quickly added to the HAuCl4 solu-
tion, left refluxing for 20  min under continuous stirring 
protected from light, and cooled down to room tempera-
ture before use. Transmission electron microscopy (TEM), 
dynamic light scattering (DLS) and UV–Vis spectroscopy 
were used to characterize the synthetized AuNPs.
BioCode Au‑nanobeacon assembly
The BioCode Au-nanobeacons were synthesized as 
described in [10]. Briefly, AuNPs were functionalized for 
45  % surface coverage with polyethylene glycol (PEG) 
using a commercial hetero-functional PEG modified 
with a thiol group O-(2-mercaptoethyl)-O’-methyl-
hexa(ethylene glycol), C15H32O7S, 356.48  Da. The 
PEGylated AuNPs (AuNP@PEG) were washed by cen-
trifugation (14,000×g, 45 min, 4 °C). For Au-nanobeacon 
conjugation, the stem-looped oligonucleotide modified 
with 3′-FAM and 5′-Thiol-C6 (STABVIDA) was sus-
pended in 1 mL of 0.1 M dithiothreitol (DTT), extracted 
three times with ethyl acetate and further purified 
through a desalting NAP-5 column (Pharmacia Biotech) 
using 10  mM phosphate buffer (pH 8) as eluent. The 
oligonucleotide was added to the PEGylated AuNP in a 
100:1 ratio and processed as previously described [10]. 
The Au-nanobeacons were centrifuged at 14,000×g for 
45 min, 4 °C, the pellet washed 3 times, and re-suspended 
in 10  mM phosphate buffer (pH 8), for a final concen-
tration of 20  nM. The resulting Au-nanobeacons were 
stored in the dark at 4 °C until further use. The BioCode 
Au-nanobeacons were characterized by DLS, UV–Vis 
spectroscopy and zeta potential. Supernatants were col-
lected for determination of number of oligonucleotides 
per nanoparticle.
Fluorescence analysis
Fluorescence emission spectra were collected on a Varian 
Cary Eclipse Fluorescence Spectrophotometer with 5 nm 
bandwidth excitation and emission slits in a 3 mm optical 
path quartz cuvette (HELLMA, Germany). The excita-
tion wavelength used was 495 nm (maximum absorption 
of FAM—donor) and 550  nm (maximum absorption 
of Cy3). Fluorescence measurements were performed 
at 20  °C. The occurrence of energy transfer (FRET) was 
determined through the increase of the intensity of fluo-
rescence band of the acceptors compared to the intensity 
of the fluorescence band of the acceptors in the control 
reaction.
Table 2 Oligonucleotide sequences used for AuNP functionalization, target specificity and acceptor labeled oligonucleo-
tides
Oligonucleotide sequence (5′–3′) 5′ modification 3′ modification
Hairpin-e13a2 ccacgccaaacgctgaagggcttcttccttatttttggcgtgg C6-Thiol 6-carboxyfluorcein
Hairpin-e14a2 cacctcgaaatctgaagggcttttgaactctgttttcgaggtg C6-Thiol Cy3
e13a2 (AJ131467.1) ataaggaagaagcccttcagcg – –
e14a2 (AJ131466.1) cagagttcaaaagcccttcag – –
Acceptor-ROX ccacgccaaa – ROX
Acceptor-Dy cacctcgaaa Dy-520XL mega stokes
BCR-e13 (NM_004327.3) tccgctgaccatcaataaggaagaa – –
BCR-e14 (NM_004327.3) cactggatttaagcagagttcaaaa – –
ABL (NM_005157.5) gcccttcagcggccagtagcatctg – –
Non-complementary attaccagacatgcgtggtcccaac – –
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Detection of target sequence
All detection/hybridization assays were performed with 
1  nM of Au-nanobeacon in 0.5 ×  TBE pH 8, 154  mM 
NaCl. For the Positive sample (POS), 500  nM of e13a2 
or e14a2 target sequence and 50  nM of the respective 
acceptor; for the Negative (NEG), 500 nM of NC target 
and 50 nM of the respective acceptor; for Donor blank, 
500 nM of complementary target and with 50 nM of the 
respective acceptor; for reaction blank water was added 
to the reaction in the presence of 50 nM of the respective 
acceptor.
To control and fully characterize the detection events, 
hybridizations were performed by (1) pre-hybridize the 
respective targets before collecting the emission spectra 
(95 °C for 30 s and 20 °C for 30 min); (2) collecting sev-
eral emission spectra before and after of addition of the 
respective targets and follow hybridization over time.
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